Cargando…

A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions

Detalles Bibliográficos
Autores principales:	Donzelli, Sara, Cioce, Mario, Sacconi, Andrea, Zanconato, Francesca, Daralioti, Theodora, Goeman, Frauke, Orlandi, Giulia, Di Martino, Simona, Fazio, Vito Michele, Alessandrini, Gabriele, Telera, Stefano, Carosi, Mariantonia, Ciliberto, Gennaro, Botti, Claudio, Strano, Sabrina, Piccolo, Stefano, Blandino, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306102/ https://www.ncbi.nlm.nih.gov/pubmed/35869553 http://dx.doi.org/10.1186/s12943-022-01617-6

Ejemplares similares

Breast cancer metastasis: Is it a matter of OMICS and proper ex-vivo models?
por: Cioce, Mario, et al.
Publicado: (2022)

HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis
por: Di Agostino, Silvia, et al.
Publicado: (2023)

Insights into Intra-Tumoral Heterogeneity: Transcriptional Profiling of Chemoresistant MPM Cell Subpopulations Reveals Involvement of NFkB and DNA Repair Pathways and Contributes a Prognostic Signature
por: Cioce, Mario, et al.
Publicado: (2021)

Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids
por: Cioce, Mario, et al.
Publicado: (2023)

MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer
por: Turco, Chiara, et al.
Publicado: (2022)

Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib
por: Morin, Gabriel, et al.
Publicado: (2022)

Metformin: Metabolic Rewiring Faces Tumor Heterogeneity
por: Cioce, Mario, et al.
Publicado: (2020)

Epigenetic silencing of miR-145-5p contributes to brain metastasis
por: Donzelli, Sara, et al.
Publicado: (2015)

Response of Brain Metastases From PIK3CA-Mutant Breast Cancer to Alpelisib
por: Batalini, Felipe, et al.
Publicado: (2020)

Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma
por: Cioce, Mario, et al.
Publicado: (2021)

Alpelisib: A Novel Therapy for Patients With PIK3CA-Mutated Metastatic Breast Cancer
por: Wilhoit, Tori, et al.
Publicado: (2020)

Successful Treatment of Hypoglycemia With Alpelisib in Pediatric Patients With PIK3CA-Related Overgrowth Spectrum
por: Nasomyont, Nat, et al.
Publicado: (2023)

Anticancer effects of alpelisib on PIK3CA-mutated canine mammary tumor cell lines
por: Yeom, Jiah, et al.
Publicado: (2023)

The Glioma-IRE project − Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach
por: Villani, Veronica, et al.
Publicado: (2023)

Mir 145/143: tumor suppressor, oncogenic microenvironmental factor or …both?
por: Cioce, Mario, et al.
Publicado: (2016)

Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America
por: Garneau, Alexandre P., et al.
Publicado: (2021)

Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives
por: Chang, Dwan-Ying, et al.
Publicado: (2021)

In vitro anticancer effects of alpelisib against PIK3CA-mutated canine hemangiosarcoma cell lines
por: Maeda, Marika, et al.
Publicado: (2022)

TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients
por: Sacconi, Andrea, et al.
Publicado: (2020)

On the connections between cancer stem cells and EMT
por: Cioce, Mario, et al.
Publicado: (2012)

Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects
por: Mori, Federica, et al.
Publicado: (2016)

Optimizing the Illumina COVIDSeq laboratorial and bioinformatics pipeline on thousands of samples for SARS-CoV-2 Variants of Concern tracking
por: Donzelli, Sara, et al.
Publicado: (2022)

Non-coding RNAs as Putative Biomarkers of Cancer-Associated Cachexia
por: Donzelli, Sara, et al.
Publicado: (2020)

Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer
por: Ronchetti, Livia, et al.
Publicado: (2022)

Correction: Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer
por: Ronchetti, Livia, et al.
Publicado: (2023)

microRNAs: short non-coding bullets of gain of function mutant p53 proteins
por: Donzelli, Sara, et al.
Publicado: (2014)

Cdx2 Polymorphism Affects the Activities of Vitamin D Receptor in Human Breast Cancer Cell Lines and Human Breast Carcinomas
por: Pulito, Claudio, et al.
Publicado: (2015)

Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities
por: Pulito, Claudio, et al.
Publicado: (2017)

Diabetic Ketoacidosis With Alpelisib
por: Jeun, Rebecca, et al.
Publicado: (2021)

Alpelisib for breast cancer
Publicado: (2022)

PIK3CA-Related Overgrowth Spectrum From Diagnosis to Targeted Therapy: A Case of CLOVES Syndrome Treated With Alpelisib
por: Pagliazzi, Angelica, et al.
Publicado: (2021)

Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity
por: Sterba, Martin, et al.
Publicado: (2023)

Metformin-induced metabolic reprogramming of chemoresistant ALDH(bright) breast cancer cells
por: Cioce, Mario, et al.
Publicado: (2014)

Alpelisib-Induced Diabetic Ketoacidosis
por: Espinosa, Luis Borges, et al.
Publicado: (2021)

Alpelisib-Induced Diabetic Ketoacidosis
por: Nguyen, Paul, et al.
Publicado: (2021)

Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation
por: Canu, Valeria, et al.
Publicado: (2020)

Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment
por: Raphael, Ari, et al.
Publicado: (2022)

The way to precision medicine in gynecologic cancers: The first case report of an exceptional response to alpelisib in a PIK3CA-mutated endometrial cancer
por: Passarelli, Anna, et al.
Publicado: (2023)

A Rare Pathological Phenotype of Endometrioid Serous and Clear-Cell Ovarian Cancer with PIK3CA Mutations in Relation to The Excellent Response of Alpelisib
por: Bayram, Ertugrul, et al.
Publicado: (2023)

Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trial
por: Muti, Paola, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i596635uaodiboe3d8qeb9ekvi